Monday 18th January 2021 GatewayC have produced a list of cancer charity support lines for people who may be worried about their cancer diagnosis, or are concerned about how COVID-19 might affect their cancer treatment. Please download this PDF resource or find the...
15th January 2021 Missed our free GatewayC webinar on Diagnosing Ovarian Cancer? Watch our recording here. In this webinar, GatewayC met Professor Gordon Jayson, Professor of Medical Oncology at The Christie NHS Foundation Trust, who answered key questions from our...
Neutropenic sepsis is a potentially fatal complication of anticancer treatment (particularly chemotherapy). Helpful hint: NICE have produced a COVID-19 rapid guideline on the delivery of systemic anticancer treatments. If patients present with COVID-19 symptoms this...
Potential pitfall: In the early course of the disease, pancreatic cancer may not cause any signs or symptoms. However, sudden onset diabetes in groups of patients for whom this would be unexpected can be an early indicator. Helpful hint: NICE NG12 guidelines recommend...
The main investigation for suspected lung cancer in primary care is a chest X-ray. However, reports show that some patients with normal chest X-rays still transpire to have lung cancer.
Although most large lung cancers can be seen on a chest X-ray, a study in the British Journal of General Practice in 2006 showed that there is a false negative rate of over 23% – more than 1 in 5.
Chest X-rays are a useful investigation, but be aware of false negative results. If a chest X-ray is negative, but there is still clinical suspicion, either refer the patient for a computed tomography (CT) scan (if available), or refer the patient via a suspected cancer pathway.
Download this Cancer Key here.
Access GatewayC’s Lung Cancer – Early Diagnosis course here.